CoChat

A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 8 of the 36 sources its claims cite were checked for support.

Abstract

Objective: Gut microbiota have been linked to inflammatory bowel disease (IBD) and colorectal cancer (CRC). Akkermansia muciniphila ( A. muciniphila ) is a gram-negative anaerobic bacterium that is selectively decreased in the faecal microbiota of patients with IBD, but its causative role and molecular mechanism in blunting colitis-associated colorectal cancer (CAC) remain inconclusive. This study investigates how A. muciniphila engages the immune response in CAC. Design: Mice were given dextran sulfate sodium to induce colitis, followed by azoxymethane to establish CAC with or without pasteurised A. muciniphila or a specific outer membrane protein (Amuc_1100) treatment. Faeces from mice and patients with IBD or CRC were collected for 16S rRNA sequencing. The effects of A. muciniphila or Amuc_1100 on the immune response in acute colitis and CAC were investigated. Results: A. muciniphila was significantly reduced in patients with IBD and mice with colitis or CAC. A. muciniphila or Amuc_1100 could improve colitis, with a reduction in infiltrating macrophages and CD8 + cytotoxic T lymphocytes (CTLs) in the colon. Their treatment also decreased CD16/32 + macrophages in the spleen and mesenteric lymph nodes (MLN) of colitis mice. Amuc_1100 elevated PD-1 + CTLs in the spleen. Moreover, A. muciniphila and Amuc_1100 blunted tumourigenesis by expanding CTLs in the colon and MLN. Remarkably, they activated CTLs in the MLN, as indicated by TNF-α induction and PD-1downregulation. Amuc_1100 could stimulate and activate CTLs from splenocytes in CT26 cell conditioned medium. Conclusions: These data indicate that pasteurised A. muciniphila or Amuc_1100 can blunt colitis and CAC through the modulation of CTLs.

Overview

CoChat Summary

TL;DR

Pasteurised *Akkermansia muciniphila* or its outer membrane protein Amuc_1100 ameliorated DSS-induced colitis and blunted AOM/DSS colitis-associated tumourigenesis in mice. The protective effects were linked to modulation of CD8+ cytotoxic T lymphocytes (CTLs), including expansion/activation in colon and mesenteric lymph nodes and reduced PD-1+ CTLs.

Key findings

  • *A. muciniphila* abundance was decreased in patients with UC, adenoma and CRC and in mice with colitis or CAC; ROC analysis for predicting UC gave AUC=0.674, p=0.0007.
  • In acute colitis, pasteurised *A. muciniphila* (1.5×10^8 CFU) or Amuc_1100 (3 µg) improved disease activity index, colon shortening, splenomegaly and histological injury, and decreased colonic proinflammatory cytokines including TNF-α, IFN-γ, IL-1β, IL-6, IL-18 and IL-33.
  • In CAC, treatment delayed tumour formation and reduced tumour numbers and area by week 12, decreased γH2AX, cleaved caspase 3 and Ki67 in colon, and increased CTLs in MLN/colon while reducing PD-1+ CTLs and increasing TNF-α+ CTLs.
  • In vitro, Amuc_1100 increased CTL proportion in splenocytes cultured in CT26-conditioned medium and CTLs pretreated with Amuc_1100 increased CT26 apoptosis, with Bcl-2 downregulation and caspase 3 upregulation.

Methods

  • Mice received 2% DSS for acute colitis or AOM (10 mg/kg) plus three cycles of 2% DSS for CAC, with or without oral pasteurised *A. muciniphila* (1.5×10^8 CFU) or Amuc_1100 (3 µg) starting 2 weeks before induction.
  • Human stool from active UC, adenoma, CRC and healthy controls underwent 16S rRNA V3 sequencing; *A. muciniphila* was quantified by qPCR and FISH.
  • Immune responses were assessed by flow cytometry, immunohistochemistry, qPCR and CT26 coculture assays; statistics used one-way ANOVA with Tukey’s multiple comparisons, t-tests and ROC analysis.

Limitations

  • The paper states that a dramatic microbial community shift was not observed in patients with adenoma or CAC because of interindividual variation and small sample size.
  • The paper states that underlying mechanisms need further investigation and that interactions between macrophages and CTLs after treatment remain unclear.
  • Evident from the text: findings are from male C57BL/6J mouse models and in vitro CT26 assays, with no human intervention testing of pasteurised *A. muciniphila* or Amuc_1100 for colitis/CAC.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2019-320105

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Decreased A. muciniphila was associated with colitis and CRC in human and mice. (A) Heatmap of faecal microbiota from patients with UC, Ad, CRC and healthy controls. (B) Comparison of the faecal microbiota among UC, Ad, CRC and controls at the phylum level. (C) FISH detection of A. muciniphila in the colon of human patients using a FITC-conjugated A. muciniphila specific probe (green). Scale bars, 50 µm. (D) qPCR validation of the relative abundance of A. muciniphila in human patients. (E) ROC curves of A. muciniphila in predicting UC. (F) Heatmap of faecal microbiota from mice with CAC at different time points. (G) Comparison of faecal microbiota in CAC mice at the phylum level. (H) FISH detection of A. muciniphila in the mice with colitis and CAC (at week 23). (I) The relative abundance of A. muciniphila in colitis and CAC (at week 23) mice by qPCR. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. ***P<0.001. Ad, adenoma; ANOVA, analysis of variance; CAC, colitis-associated colorectal cancer; CRC, colorectal cancer; UC, ulcerative colitis
Figure 1 Decreased A. muciniphila was associated with colitis and CRC in human and mice. (A) Heatmap of faecal microbiota from patients with UC, Ad, CRC and healthy controls. (B) Comparison of the faecal microbiota among UC, Ad, CRC and controls at the phylum level. (C) FISH detection of A. muciniphila in the colon of human patients using a FITC-conjugated A. muciniphila specific probe (green). Scale bars, 50 µm. (D) qPCR validation of the relative abundance of A. muciniphila in human patients. (E) ROC curves of A. muciniphila in predicting UC. (F) Heatmap of faecal microbiota from mice with CAC at different time points. (G) Comparison of faecal microbiota in CAC mice at the phylum level. (H) FISH detection of A. muciniphila in the mice with colitis and CAC (at week 23). (I) The relative abundance of A. muciniphila in colitis and CAC (at week 23) mice by qPCR. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. ***P<0.001. Ad, adenoma; ANOVA, analysis of variance; CAC, colitis-associated colorectal cancer; CRC, colorectal cancer; UC, ulcerative colitisCC BY-NC · PubMed Central
Figure 2 Supplementation with pasteurised A. muciniphila or Amuc_1100 improved colitis induced by DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) (DAI, (C) colon length and (D) spleen weight were analysed. (E) Representative histological images of colon tissues by H&E staining. Scale bars, 200 µm. (F) IHC staining and quantitation of cleaved-caspase 3 in the proximal colon. Scale bars, 50 µm. (G) The mRNA expression of proinflammatory cytokines in colon tissue, including TNF-α, IFN-γ, IL-1β, IL-6, IL-18 and IL-33. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; ##p<0.01, ###p<0.001, compared with DSS group. ANOVA, analysis of variance; DAI, disease activity index; DSS, dextran sulfate sodium; IHC, immunohistochemistry.
Figure 2 Supplementation with pasteurised A. muciniphila or Amuc_1100 improved colitis induced by DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) (DAI, (C) colon length and (D) spleen weight were analysed. (E) Representative histological images of colon tissues by H&E staining. Scale bars, 200 µm. (F) IHC staining and quantitation of cleaved-caspase 3 in the proximal colon. Scale bars, 50 µm. (G) The mRNA expression of proinflammatory cytokines in colon tissue, including TNF-α, IFN-γ, IL-1β, IL-6, IL-18 and IL-33. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; ##p<0.01, ###p<0.001, compared with DSS group. ANOVA, analysis of variance; DAI, disease activity index; DSS, dextran sulfate sodium; IHC, immunohistochemistry.CC BY-NC · PubMed Central
Figure 3 Supplementation with pasteurised A. muciniphila or Amuc_1100 suppressed the activation and infiltration of CD8+ CTLs and macrophages in colitis mice. Representative FCM analysis and quantification of CTLs (A) and PD1+ CTLs (B) in the spleen. Representative FCM analysis and quantification of CD16/32+ macrophages (CD11b+F4/80+) (C) and PD1+ CD16/32+ macrophages (D) in the spleen. Scale bars, 50 µm. Representative FCM analysis and quantification of CD16/32+ macrophages (E) and PD1+ CD16/32+ macrophage (F) in the MLN. IHC staining of CD8a (G) and F4/80 (H) in the proximal colon. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; #p<0.05, ##p<0.01, ###p<0.001, compared with DSS group. ANOVA, analysis of variance; CTL, cytotoxic T lymphocytes; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry; MLN, mesenteric lymph nodes.
Figure 3 Supplementation with pasteurised A. muciniphila or Amuc_1100 suppressed the activation and infiltration of CD8+ CTLs and macrophages in colitis mice. Representative FCM analysis and quantification of CTLs (A) and PD1+ CTLs (B) in the spleen. Representative FCM analysis and quantification of CD16/32+ macrophages (CD11b+F4/80+) (C) and PD1+ CD16/32+ macrophages (D) in the spleen. Scale bars, 50 µm. Representative FCM analysis and quantification of CD16/32+ macrophages (E) and PD1+ CD16/32+ macrophage (F) in the MLN. IHC staining of CD8a (G) and F4/80 (H) in the proximal colon. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; #p<0.05, ##p<0.01, ###p<0.001, compared with DSS group. ANOVA, analysis of variance; CTL, cytotoxic T lymphocytes; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry; MLN, mesenteric lymph nodes.CC BY-NC · PubMed Central
Figure 4 Supplementation with pasteurised A. muciniphila or Amuc_1100 blunted tumourigenesis induced by azoxymethane (AOM)/DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) DAI, (C) spleen weight, (D) tumour development, number (E) and tumour area (F) were analysed. (G) Representative histological images of colon tissues by H&E staining. Scale bars, 200 µm. IHC staining and quantitation of γH2AX (8 weeks, H), cleaved-caspase 3 (23 weeks, I) and Ki67 (23 weeks, J) in the proximal colon. Scale bars, 50 µm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; #p<0.05, ##p<0.01, ###p<0.001, compared with AOM+DSS group. ANOVA, analysis of variance; DAI, disease activity index; DSS, dextran sulfate sodium; IHC, immunohistochemistry.
Figure 4 Supplementation with pasteurised A. muciniphila or Amuc_1100 blunted tumourigenesis induced by azoxymethane (AOM)/DSS. (A) Weight changes are expressed as the mean change from the starting weight. (B) DAI, (C) spleen weight, (D) tumour development, number (E) and tumour area (F) were analysed. (G) Representative histological images of colon tissues by H&E staining. Scale bars, 200 µm. IHC staining and quantitation of γH2AX (8 weeks, H), cleaved-caspase 3 (23 weeks, I) and Ki67 (23 weeks, J) in the proximal colon. Scale bars, 50 µm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with respective control; #p<0.05, ##p<0.01, ###p<0.001, compared with AOM+DSS group. ANOVA, analysis of variance; DAI, disease activity index; DSS, dextran sulfate sodium; IHC, immunohistochemistry.CC BY-NC · PubMed Central
Figure 5 Pasteurised A. muciniphila or Amuc_1100 enhanced CTLs activation in CAC mice. FCM analysis of CTLs, PD-1+ CTLs and TNF-α+ CTLs in the MLN in the 12th week (A). Quantification of CTLs (B), PD-1+ CTLs (C) and TNF-α CTLs (D) in the 8th, 12th and 23rd week, respectively. (E) IHC staining of CD8a in the colon. Scale bars, 50 µm. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with control; #p<0.05, ##p<0.01, ###p<0.001, compared with AOM+DSS group. ANOVA, analysis of variance; AOM, azoxymethane; CAC, colitis-associated colorectal cancer; CTL, cytotoxic T lymphocyte; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry.
Figure 5 Pasteurised A. muciniphila or Amuc_1100 enhanced CTLs activation in CAC mice. FCM analysis of CTLs, PD-1+ CTLs and TNF-α+ CTLs in the MLN in the 12th week (A). Quantification of CTLs (B), PD-1+ CTLs (C) and TNF-α CTLs (D) in the 8th, 12th and 23rd week, respectively. (E) IHC staining of CD8a in the colon. Scale bars, 50 µm. Data are presented as the means±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with control; #p<0.05, ##p<0.01, ###p<0.001, compared with AOM+DSS group. ANOVA, analysis of variance; AOM, azoxymethane; CAC, colitis-associated colorectal cancer; CTL, cytotoxic T lymphocyte; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry.CC BY-NC · PubMed Central
Figure 6 The reduced proportion and infiltration of macrophages in CAC mice treated with pasteurised A. muciniphila or Amuc_1100. (A) FCM analysis and (B) quantification of macrophage (CD11b+F4/80+) in lymphocytes of the spleen in the 8th, 12th and 23rd week. (C) IHC of F4/80 in the colon. Scale bars,50 μm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with control; #p<0.05, ##p<0.01, ###p<0.0001, compared with AOM+DSS group. ANOVA, analysis of variance; AOM, azoxymethane; CAC, colitis-associated colorectal cancer; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry.
Figure 6 The reduced proportion and infiltration of macrophages in CAC mice treated with pasteurised A. muciniphila or Amuc_1100. (A) FCM analysis and (B) quantification of macrophage (CD11b+F4/80+) in lymphocytes of the spleen in the 8th, 12th and 23rd week. (C) IHC of F4/80 in the colon. Scale bars,50 μm. Data are presented as the mean±SEM and were analysed by ordinary one-way ANOVA with Tukey’s multiple comparisons. *P<0.05, **p<0.01, ***p<0.001, compared with control; #p<0.05, ##p<0.01, ###p<0.0001, compared with AOM+DSS group. ANOVA, analysis of variance; AOM, azoxymethane; CAC, colitis-associated colorectal cancer; DSS, dextran sulfate sodium; FCM, flow cytometry; IHC, immunohistochemistry.CC BY-NC · PubMed Central
Figure 7 Amuc_1100 induced CTL activation in CT26 cell conditioned medium. (A) Schematic representation of CTL isolation and coculture with CT26 cells. (B) The fraction of CTLs in the splenocytes cultured with CT26 cell conditioned medium with or without Amuc_1100 for 72 hours. (C) The apoptotic rate of CT26 cells cocultured with sorted CTLs for 48 hours (n=3). The mRNA expression of Bcl-2 (D) and caspase 3 (E) and in CT26 cells was detected by qPCR. (F) Intratumoural cleaved-caspase 3 in CAC mice were analysed by IHC. Scale bars, 20 µm. Data are presented as the means±SEM and were analysed with t test. *P<0.05, **p<0.01, ***p<0.001, compared with control. CAC, colitis-associated colorectal cancer; CTL, cytotoxic T lymphocyte; IHC, immunohistochemistry.
Figure 7 Amuc_1100 induced CTL activation in CT26 cell conditioned medium. (A) Schematic representation of CTL isolation and coculture with CT26 cells. (B) The fraction of CTLs in the splenocytes cultured with CT26 cell conditioned medium with or without Amuc_1100 for 72 hours. (C) The apoptotic rate of CT26 cells cocultured with sorted CTLs for 48 hours (n=3). The mRNA expression of Bcl-2 (D) and caspase 3 (E) and in CT26 cells was detected by qPCR. (F) Intratumoural cleaved-caspase 3 in CAC mice were analysed by IHC. Scale bars, 20 µm. Data are presented as the means±SEM and were analysed with t test. *P<0.05, **p<0.01, ***p<0.001, compared with control. CAC, colitis-associated colorectal cancer; CTL, cytotoxic T lymphocyte; IHC, immunohistochemistry.CC BY-NC · PubMed Central

Verification

Claims the paper makes

8 Valid · 0 Not valid · 20 Not checked · 87 Own results and interpretations

62 more claims

Create a free account to see all 115 claims and to verify the 28 references still open.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 27

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 50 references

Cited by

See all 632

Metadata

Authors
Wang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., Li, L., & Zhang, Z.
Affiliations
  • Nanjing Medical University (CN)
  • Nanjing University of Chinese Medicine (CN)
Corresponding author
Zhang, Zhan
Venue
Gut
Publisher
BMJ
Published
2020-03-13
Volume
69
Issue
11
Pages
1988-1997
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3012095940
Cited by
630
References
50
Citations by year
2026: 75 · 2025: 141 · 2024: 119 · 2023: 110 · 2022: 106 · 2021: 68 · 2020: 11
FWCI
23.93
Type
journal article
Language
en
Open access
Locations
  • Gut (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • the National Natural Science Foundations of China (81502801, 81973096)
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX18_1513)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
Akkermansia muciniphila, colitis-associated colorectal cancer, CD8+ T cells, cytotoxic T lymphocytes, Amuc_1100, outer membrane proteins, gut microbiota, inflammatory bowel disease, DSS-induced colitis, azoxymethane, macrophages, PD-1, TNF-α, mesenteric lymph nodes
MeSH terms
Colitis-Associated Neoplasms, Akkermansia, Animals, Colitis, Disease Models, Animal, Feces, Female, Humans, Male, Membrane Proteins, CD8-Positive T-Lymphocytes, Mice, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice. https://app.cochat.ai/papers/10.1136/gutjnl-2019-320105
The paper
Wang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., Li, L., & Zhang, Z. (2020). A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8 + T cells in mice. Gut. https://doi.org/10.1136/gutjnl-2019-320105

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.